MiNK Therapeutics Inc.

NASDAQ:INKT

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.

The Conversation (0)
MARKETS
COMMODITIES
CURRENCIES